Maryland Statutes
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2C - Prescription Drug Affordability Board

Section 21-2C-01 - Definitions - (a) In this subtitle the following words have the meanings...

Section 21-2C-02 - Prescription Drug Affordability Board - (a) (1) There is a Prescription Drug Affordability Board. (2)...

Section 21-2C-03 - Membership - (a) (1) The Board consists of the following members, who...

Section 21-2C-04 - Prescription Drug Affordability Stakeholder Council - (a) There is a Prescription Drug Affordability Stakeholder Council. (b)...

Section 21-2C-05 - Disclosure of Conflicts of Interest - (a) (1) A conflict of interest shall be disclosed: (i)...

Section 21-2C-06 - Acceptance of Gratuities Prohibited - Members and alternate members of the Board, Board staff, and...

Section 21-2C-07 - Study and Report -- Pharmaceutical Distribution and Payment System in State; Policy Options Used in Other States and Countries - On or before December 31, 2021, the Board, in consultation...

Section 21-2C-08 - Collection, Review, and Use of Transparency Data for Prescription Drug Products - (a) On or before December 31, 2021, the Board shall:...

Section 21-2C-09 - Cost Review of Prescription Drug Products With Affordability Challenges - (a) (1) After identifying prescription drug products as required by...

Section 21-2C-10 - Confidentiality - (a) All information and data obtained by the Board under...

Section 21-2C-11 - Funding Source - (a) In this section, “Fund” means the Prescription Drug Affordability...

Section 21-2C-12 - Enforcement - The Office of the Attorney General may pursue any available...

Section 21-2C-13 - Drafting Action Plan for Implementing Process to Set Upper Payment Limits for Prescription Drug Products - (a) On or after January 1, 2022, the Board may...

Section 21-2C-14 - Setting Upper Payment Limits for Prescription Drug Products - (a) On or after January 1, 2022, the Board, in...

Section 21-2C-15 - Appeals of Board Decisions - (a) A person aggrieved by a decision of the Board...

Section 21-2C-16 - Board and Stakeholder Council Report and Recommendation Concerning Upper Payment Limits - On or before December 1, 2023, the Board, in consultation...